AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
Stock Snapshot
AbbVie(ABBV) stock is priced at $295.50, giving the company a market capitalization of 522.32B. It carries a P/E multiple of 50.68 and pays a dividend yield of 2.35%.
As of 2026-11-13, AbbVie(ABBV) stock has fluctuated between $293.56 and $297.25. The current price stands at $295.50, placing the stock +0.7% above today's low and -0.6% off the high.
The AbbVie(ABBV)'s current trading volume is 1.68M, compared to an average daily volume of 6M.
In the last year, AbbVie(ABBV) shares hit a 52-week high of $302.93 and a 52-week low of $190.75.
In the last year, AbbVie(ABBV) shares hit a 52-week high of $302.93 and a 52-week low of $190.75.
ABBV News
Abbvie (ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s official study, “A Post-marketing Non-interventional Study for Upad...
Chicago, IL – November 12, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the...
AbbVie’s (ABBV Quick QuoteABBV - Free Report) stock has risen 4.5% in a month, mainly driven by its robust third-quarter performance. Third-quarter adjus...
Analyst ratings
77%
of 30 ratingsMore ABBV News
...
AbbVie (ABBV) said Sunday that patients taking GLP-1 weight-loss medications reported improved satisfaction with their facial appearance following cosmetic trea...
Investing Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027? A blockbuster blood thinner is about to lose $1.5 billion to $2 billion in sales,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.